Literature DB >> 21143413

Feasibility study of an intensity-modulated radiation model for the study of erectile dysfunction.

Bridget F Koontz1, Hui Yan, Masaki Kimura, Zeljko Vujaskovic, Craig Donatucci, Fang-Fang Yin.   

Abstract

INTRODUCTION: Preclinical studies of radiotherapy (RT) induced erectile dysfunction (ED) have been limited by radiation toxicity when using large fields. AIM: To develop a protocol of rat prostate irradiation using techniques mimicking the current clinical standard of intensity modulated radiotherapy (IMRT). MAIN OUTCOME MEASURES: Quality assurance (QA) testing of plan accuracy, animal health 9 weeks after RT, and intracavernosal pressure (ICP) measurement on cavernosal nerve stimulation.
METHODS: Computed tomography-based planning was used to develop a stereotactic radiosurgery (SRS) treatment plan for five young adult male Sprague-Dawley rats. Two treatment planning strategies were utilized to deliver 20 Gy in a single fraction: three-dimensional dynamic conformal arc and intensity-modulated arc (RapidArc). QA testing was performed for each plan type. Treatment was delivered using a NovalisTX (Varian Medical Systems) with high-definition multi-leaf collimators using on-board imaging prior to treatment. Each animal was evaluated for ED 2 months after treatment by nerve stimulation and ICP measurement.
RESULTS: The mean prostate volume and target volume (5 mm expansion of prostate) for the five animals was 0.36 and 0.66 cm3, respectively. Both conformal and RapidArc plans provided at least 95% coverage of the target volume, with rapid dose fall-off. QA plans demonstrated strong agreement between doses of calculated and delivered plans, although the conformal arc plan was more homogenous in treatment delivery. Treatment was well tolerated by the animals with no toxicity out to 9 weeks. Compared with control animals, significant reduction in ICP/mean arterial pressure, maximum ICP, and ICP area under the curve were noted.
CONCLUSION: Tightly conformal dynamic arc prostate irradiation is feasible and results in minimal toxicity and measurable changes in erectile function.
© 2010 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2010        PMID: 21143413     DOI: 10.1111/j.1743-6109.2010.02125.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  4 in total

1.  Influence of vascular comorbidities and race on erectile dysfunction after prostate cancer radiotherapy.

Authors:  Yuefeng Wang; Tian Liu; Peter J Rossi; Deborah Watkins-Bruner; Wayland Hsiao; Sherrie Cooper; Xiaofeng Yang; Ashesh B Jani
Journal:  J Sex Med       Date:  2013-06-06       Impact factor: 3.802

2.  Effects of intravenous injection of adipose-derived stem cells in a rat model of radiation therapy-induced erectile dysfunction.

Authors:  Xuefeng Qiu; Jacqueline Villalta; Ludovic Ferretti; Thomas M Fandel; Maarten Albersen; Guiting Lin; Yutian Dai; Tom F Lue; Ching-Shwun Lin
Journal:  J Sex Med       Date:  2012-04-30       Impact factor: 3.802

Review 3.  Tumour and normal tissue radiobiology in mouse models: how close are mice to mini-humans?

Authors:  Bridget F Koontz; Frank Verhaegen; Dirk De Ruysscher
Journal:  Br J Radiol       Date:  2016-09-26       Impact factor: 3.039

Review 4.  Radiation-induced erectile dysfunction: Recent advances and future directions.

Authors:  Javed Mahmood; Aksinija A Shamah; T Michael Creed; Radmila Pavlovic; Hotaka Matsui; Masaki Kimura; Jason Molitoris; Hem Shukla; Isabel Jackson; Zeljko Vujaskovic
Journal:  Adv Radiat Oncol       Date:  2016-06-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.